Could a plant extract help calm delirium? first human trial begins
NCT ID NCT07422142
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage study will test whether an injection of gastrodin, a compound from a traditional Chinese herb, is safe and tolerable in 54 healthy adults. Researchers will also measure how the drug moves through the body. If successful, this could lead to larger studies in patients with delirium, a sudden confused state often seen in hospital settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
gastrodin injection
What this could lead to
If this early safety study succeeds, it could pave the way for a new treatment to ease delirium symptoms in hospitalized patients.
What could go wrong
This is a very early Phase 1 trial in only 54 healthy people, not patients with delirium. It tests safety, not effectiveness, so it may not lead to a working treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DELIRIUM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Tianjin, Tianjin Municipality, China